Lapatinib - Overview and Current Role in Metastatic Breast Cancer
Arlene Chan
Cancer Res Treat. 2006;38(4):198-200. Published online 2006 Dec 31 DOI: https://doi.org/10.4143/crt.2006.38.4.198
Citations to this article as recorded by 
The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms
Malihe Rezaee, Fatemeh Mohammadi, Atoosa Keshavarzmotamed, Sheida Yahyazadeh, Omid Vakili, Yaser Eshaghi Milasi, Vida Veisi, Rohollah Mousavi Dehmordi, Sepideh Asadi, Seyedeh Sara Ghorbanhosseini, Mehdi Rostami, Mina Alimohammadi, Abbas Azadi, Nushin Mous
Frontiers in Pharmacology.2023;[Epub] CrossRef
Circular RNA circ-MMP11 Contributes to Lapatinib Resistance of Breast Cancer Cells by Regulating the miR-153-3p/ANLN Axis
Xiaoli Wu, Yi Ren, Rong Yao, Leilei Zhou, Ruihua Fan
Frontiers in Oncology.2021;[Epub] CrossRef
Activated estrogen receptor‐mitogen‐activated protein kinases cross talk confer acquired resistance to lapatinib
Zhe Li, Sheng‐Sheng Yang, Pei‐Hao Yin, Tao Chang, Lin‐Xiang Shi, Lin Fang, Guo‐En Fang
Thoracic Cancer.2015; 6(6): 695. CrossRef
Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience
Jae-Cheol Jo, Myoung Joo Kang, Jeong Eun Kim, Jin-Hee Ahn, Kyung Hae Jung, Gyungyub Gong, Hak Hee Kim, Seung Do Ahn, Su Ssan Kim, Byung Ho Son, Sei Hyun Ahn, Sung-Bae Kim
Cancer Chemotherapy and Pharmacology.2013; 72(1): 201. CrossRef
Lapatinib – kezelési lehetőség trastuzumab-rezisztens emlőrákban
Béla Pikó
Magyar Onkológia.2009; 53(4): 369. CrossRef